Frequently Asked Questions
The market is segmented based on Global Vasomotor Menopausal Symptoms (VMS) Treatment Market, By Drug Class (Antidepressants, Hormone Therapy, Anticonvulsant, and Others), Route of Administration (Oral, Parenteral, and Others), End-Users (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others) – Industry Trends and Forecast to 2031.
.
The Global Vasomotor Menopausal Symptoms Vms Treatment Market size was valued at USD 17.75 USD Billion in 2023.
The Global Vasomotor Menopausal Symptoms Vms Treatment Market is projected to grow at a CAGR of 6.2% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
